Combined glue embolization and excision for the treatment of venous malformations
Authors:
- Rush H. ChewningRCRush H. Chewning
- Eric J. MonroeEMEric J. Monroe
- Antoinette LindbergALAntoinette Lindberg
- Kevin S. H. KooKKKevin S. H. Koo
- Basavaraj V. GhodkeBGBasavaraj V. Ghodke
- Kenneth W. GowKGKenneth W. Gow
- Patrick J. JavidPJPatrick J. Javid
- Thomas M. JingujiTJThomas M. Jinguji
- Jonathan A. PerkinsJPJonathan A. Perkins
- Giridhar M. ShivaramGSGiridhar M. Shivaram
Open Access
- 25 October 2018
- journal article
- research article
- Published by Springer Nature in CVIR Endovascular
- Vol. 1 (1) , 1-8
Abstract
The purpose of this study was to evaluate safety, technical success, and clinical outcomes of treatment for venous malformations using n-BCA glue embolization immediately prior to excision. Sixty three patients (22 male, 41 female; mean age 12 years (range 1–25)) who underwent 70 procedures for extremity and trunk venous malformations were reviewed. Indications for treatment included pain (100%), swelling (22%), and diminished range of motion (16%). Thirty seven patients (59%) had undergone prior stand-alone interventional or surgical treatment but were persistently symptomatic. Safety, technical and clinical success were retrospectively assessed. Embolization was technically successful in 100% of patients. Mean lesion size was 3.0 × 2.9 × 5.7 cm. Three patients (5%) underwent planned, second stage procedures for lesions intentionally not treated at the first procedure. Four patients (6%) underwent an unplanned, second stage procedure for residual disease after the primary operation. Mean and median follow-up duration were 18 and 17 months, respectively (range 3 to 35 months). Symptomatic improvement was achieved in 58 patients (92%), of whom 41 (65%) reported complete elimination of pain. There were no recognized instances of nontarget embolization or other complications of the interventional procedure. One patient required additional surgery for wound dehiscence and one patient developed an abscess requiring incision and drainage. Minor surgical complications included surgical site skin infections (n = 5) and numbness (n = 1). Mean and median surgical blood loss volumes were 131 mL and 10 mL, respectively. One patient required perioperative blood transfusion. Extremity and truncal venous malformations can be safely and effectively treated in a single-stage fashion using glue embolization immediately preceding excision.Keywords
This publication has 18 references indexed in Scilit:
- Interventional Management of Vascular MalformationsTechniques in Vascular and Interventional Radiology, 2011
- Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformationsNature Genetics, 2008
- Genetic causes of vascular malformationsHuman Molecular Genetics, 2007
- New Approaches to the Treatment of Congenital Vascular Malformations (CVMs)—A Single Centre ExperienceEuropean Journal of Vascular and Endovascular Surgery, 2005
- Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapyEuropean Journal of Radiology, 2005
- Glomuvenous Malformation (Glomangioma) and Venous MalformationArchives of Dermatology, 2004
- Percutaneous Treatment of Low Flow Vascular MalformationsJournal of Vascular and Interventional Radiology, 2004
- Critical Issues in Management of Congenital Vascular MalformationAnnals of Vascular Surgery, 2004
- The Use of Cyanoacrylate Adhesives in the Management of Congenital Vascular MalformationsSeminars in Interventional Radiology, 2004
- The Use of Cyanoacrylate Adhesives in Peripheral EmbolizationJournal of Vascular and Interventional Radiology, 2001